Article Versions Notes

Efrem IC, Moța M, Vladu IM, Mitrea A, Clenciu D, Timofticiuc DCP, Diaconu I-D, Turcu A, Crișan AE, Geormăneanu C, et al. A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes. Diagnostics. 2022; 12(10):2426. https://doi.org/10.3390/diagnostics12102426

Efrem, Ion Cristian, Maria Moța, Ionela Mihaela Vladu, Adina Mitrea, Diana Clenciu, Diana Cristina Protasiewicz Timofticiuc, Ileana-Diana Diaconu, Adina Turcu, Anda Elena Crișan, Cristiana Geormăneanu, and et al. 2022. "A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes" Diagnostics 12, no. 10: 2426. https://doi.org/10.3390/diagnostics12102426

Efrem, I. C., Moța, M., Vladu, I. M., Mitrea, A., Clenciu, D., Timofticiuc, D. C. P., Diaconu, I.-D., Turcu, A., Crișan, A. E., Geormăneanu, C., Glodeanu, A. D., Mahler, B., Tudor, M. S., Amzolini, A. M., Micu, S. E., Barău Abu Alhija, A., Mită, A., Filip, M. M., & Forțofoiu, M. (2022). A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes. Diagnostics, 12(10), 2426. https://doi.org/10.3390/diagnostics12102426